KKR Invests in Precipart to Accelerate Growth

October 24, 2023

KKR has agreed to invest in Precipart, a Swiss contract manufacturer of precision components for the medical device, aerospace and industrial markets. The Laubscher family will retain a significant minority stake; KKR is investing through its Health Care Strategic Growth Fund II to support Precipart's organic growth and M&A-driven expansion. Financial terms were not disclosed.

Buyers
KKR, KKR Health Care Strategic Growth Fund II
Targets
Precipart
Industry
Manufacturing
Location
Switzerland
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.